University of Minnesota. Driven to Discover.
Genomic analysis suggests C difficile strains that have spread in hospitals belong to an emerging species.
One patient is dead and one ill after contracting drug-resistant E coli after FMT.
The drug cut the incidence of C difficile by 2.4 percentage points—a 71% relative risk reduction.
Patients incorrectly labeled as allergic to penicillin are more likely to receive broad-spectrum antibiotics, a practice that promotes resistance.
Healthcare-related CDI fell from 5.9 to 4.3 per 10,000 patient-days, a 27% reduction.
Adding ultraviolet light to standard room cleaning modestly decreases hospital-wide superbugs.
IDSA/SHEA guidelines recommend fecal microbiota transplantation for patients with multiple recurrences.
A 3-track system would offer key advantages to the FDA's approach, the experts say.
Rates of prevention of recurrent C diff were similar, with fewer side effects.
The data show emergency department visits, among other factors, increase C difficile risk.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.